Registration

Monday Nov 13
6:00 pm

Opening

Monday Nov 13
7:00 pm

Keynote Address

   At the NOS main auditorium

“Proyecto Dengue en Iquitos, Peru”

Tom W. Scott (U of California-Davis, US/Peru)

Monday Nov 13
8:00 pm

Welcoming Reception

   At the NOS 14th floor

Tuesday Nov 14
8:30 am – 10:00 am

Epidemiology / Phylogenetics

   At the NOS main auditorium

“Insights from mathematical modelling in understanding the potential of Wolbachia to control arboviruses”

Henrik Salje (U of Cambridge, UK)

“Butantan Dengue vaccine phase 3 results”

Mauricio Nogueira (FAMERP, Brazil)

“Chikungunya transmission during the COVID-19 pandemic: A cohort study in an urban informal settlement”

Jaqueline S. Cruz (Fiocruz-Bahia, Brazil)

“Prior Zika or Dengue virus infection increases risk of subsequent symptomatic infection by Dengue virus serotypes 2, 3, and 4 but not serotype 1”

José Victor Zambrana (Sustainable Sciences Inst., Nicaragua)

“Oropouche virus as an emerging cause of acute febrile illness in Colombia”

Jorge Osorio (U of Winsconsin-Madison, USA)

Tuesday Nov 14
10:00 am – 10:30 am

   Coffee break

   At the NOS 4th floor

Tuesday Nov 14
10:30 am – 12:00 pm

Modeling / Public Health / Burden of Disease

   At the NOS main auditorium

“Immune landscapes of Dengue virus”

Derek Cummings (U of Florida, US)

“Global arbovirus initiative: Preparing for the next pandemic by tackling mosquito-borne viruses with epidemic and pandemic potential”

Diana Rojas (PAHO)

“Projecting the public health impact of a novel Dengue vaccine using model-derived efficacy estimates”

Manar Alkuzweny (U Notre Dame, US)

“Developing a Dengue virus lineage system to improve genomic surveillance”

Verity Hill (Yale U, US)

“Genomic surveillance of CHIKV circulating in Argentina 2023”

Cintia Fabbri (ANLIS, Argentina)

Tuesday Nov 14
12:00 pm – 1:30 pm

   Lunch

   At the NOS 4th floor

Tuesday Nov 14
1:30 pm – 3:00 pm

Vector Biology / Vector-Virus Interactions

   At the NOS main auditorium

“The mosquito virome and the implications for vector competence”

Joao T. Marques (U Federal de Minas Gerais, Brazil)

“Mosquito-Virus interactions and Zika virus emergence”

Louis Lambrechts (Inst. Pasteur, France)

“Modifications caused by the NS1 protein of the Dengue virus in the intestinal epithelium of the Aedes aegypti mosquito favor virus dissemination”

Edgar Quezada (IPN, Mexico)

“H3 histone methylations patterns in the midgut of Aedes aegypti mosquitoes infected with Dengue virus serotype-2”

Grecia Hernández (CISEI, Mexico)

“16S rRNA Metagenomic characterization of individual midgut microbiota of Aedes aegypti larvae from hatchery and two localities of Tumbes, Peru”

Omar Melo (U Peruana Cayetano Heredia, Peru)

Tuesday Nov 14
3:00 pm – 3:30 pm

   Coffee break

   At the NOS 4th floor

Tuesday Nov 14
3:30 pm – 5:00 pm

Ecology / Vector Control

   At the NOS main auditorium

“Harnessing heterogeneity to guide innovative Aedes aegypti control interventions in urban areas”

Gonzalo Vasquez-Prokopec (Emory U, US/Argentina)

“Wolbachia method: results and perspectives”

Gabriel Sylvestre Ribeiro (World Mosquito Program, Brazil)

“Rapid detection of Dengue virus natural infection in Aedes aegypti from Peru by combined, portable real-time quantitative polymerase chain reaction and next generation sequencing”

Marisa Lozano (Vysnova Partners, Peru)

“The Asian tiger mosquito invasion story in forest of Central Africa and potential consequences in a One Health perspective”

Judicaël Obame-Nkoghe (U des Sciences et Techniques de Masuku, Gabon)

“Exploring Aedes aegypti dynamics through Wolbachia replacement and hybrid suppress-then-replace strategies for Dengue control”

Katie Tiley (CMMID, UK)

Tuesday Nov 14
5:00 pm – 5:30 pm

   Coffee break

   At the NOS 4th floor

Tuesday Nov 14
5:30 pm – 6:30 pm

Round Table: Vaccines

   At the NOS main auditorium

Moderator: Albert Ko (Yale U., US)

Panelists

Anna Durbin (Jonhs Hopkins U, US)
Derek Wallace (Takeda, Japan)
Gabriela Paz-Bailey (CDC Dengue Branch, US)
Aravinda de Silva (U of North Carolina-Chapel Hill, US)
German Añez (MSD, US)

Tuesday Nov 14
6:30 pm – 8:00 pm

Poster Session A

   At the NOS 5th floor 

Exhibition of posters for the following categories:

• Diagnostics – Prognostics – Clinical
• Immunology – Vaccines
• Vector Biology – Ecology – Control

Wednesday Nov 15
8:30 am – 10:00 am

Virology

   At the NOS main auditorium

“What makes an effective live-attenuated vaccine? New insights into molecular mechanisms driving the innate cellular response to yellow fever virus 17D (YFV-17D)”

Sonja Best (NIAID/NIH, US)

“Molecular studies on the 3’UTR of the Chikungunya virus genome”

Claudia Filomatori (U de San Martin, Argentina)

“Identification of an essential RNA element located just downstream of the stop codon in the Dengue virus genome”

Diego Ojeda (CONICET, Argentina)

“Cornering arboviruses to their arthropod vectors”

Gonzalo Moratorio (Inst. Pasteur, Uruguay)

“Mayaro virus pathogenesis and immunity in rhesus macaques”

Withney Weber (Oregon Health & Science U, US)

Wesdnesday Nov 15
10:00 am – 10:30 am

   Coffee break

   At the NOS 4th floor

Wednesday Nov 15
10:30 am – 12:00 pm

Virology / Pathogenesis

   At the NOS main auditorium

“Genetic screens expose ER protein biogenesis as achilles heel for Dengue virus replication”

Jan Carette (Standford U, US)

“Searching for new functions and protein-interactions of the Dengue virus NS1 protein”

Juan Ludert (CINVESTAV, Mexico)

“Accumulation of Zika virus noncoding subgenomic flavivirus RNAs downregulates the translation of antiviral genes in human host”

Horacio Pallarés (IIBA-CONICET, Argentina)

“Genetic ancestry-associated differences in Dengue virus infection in human skin”

Michelle Martí (U of Pittsburgh, US)

“Viral protein synthesis as a potential anti-viral target“

Raul Andino (U of California-San Francisco, US)

Wesdnesday Nov 15
12:00 pm – 1:30 pm

   Lunch

   At the NOS 4th floor

Wednesday Nov 15
1:30 pm – 3:00 pm

Pathogenesis / Antivirals

   At the NOS main auditorium

“Structural studies of Dengue/Zika virus antibody/antigen complexes”

Felix Rey (Inst. Pasteur, France)

“Multidisciplinary research on neglected arboviruses at the Brazilian synchrotron source”

Rafael Marques (CNPEM, Brazil)

“Induction of a pro-inflammatory profile in human polarized macrophages following Chikungunya virus infection”

Félix Delgado (U El Bosque, Colombia)

“Spondweni virus infection in pregnant rhesus macaques causes prolonged viremia and no apparent fetal harm”

Hunter Ries (U of Wisconsin-Madison, US)

“Monoclonal antibody against Zika Virus E protein EDI/II domain confers protection in immunocompromised mice”

Bianca Almeida (U de São Paulo, Brazil)

Wesdnesday Nov 15
3:00 pm – 3:30 pm

   Coffee break

   At the NOS 4th floor

Wednesday Nov 15
3:30 pm – 5:00 pm

Clinical

   At the NOS main auditorium

“Dengue severity by serotype in 19 years of pediatric studies in Nicaragua”

Federico Narvaez (Sustainable Sciences Inst., Nicaragua)

“Development of maternal neutralizing antibodies during pregnancy post Zika virus infection is associated with lower risk of microcephaly and structural brain abnormalities in exposed infants”

Karin Nielsen-Saines (U of California-Los Angeles, US)

“Clinical characterization and severity of patients diagnosed with Dengue in different age groups during the 2019 Dengue epidemic in Brazil”

Flora Gandolfi (LPV – FAMERP, Brazil)

“Dengue virus serologic prevalence and prospective cohort in adult population from metropolitan area of Medellín, Colombia 2018-2022”

Andrea Trujillo-Correa (U de Antioquia, Colombia)

“Characteristics of Dengue index cases enrolled to prospective phase 0 study of Dengue infection in index cases and household contacts in Nha Trang – Vietnam”

Lisbeth Van Wesenbeeck (Janssen, Belgium)

Wesdnesday Nov 15
5:00 pm – 5:15 pm

   Coffee break

   At the NOS 4th floor

 Wednesday Nov 15
5:15 pm – 6:15 pm

Arbovirus research in Peru

   At the NOS main auditorium

“Situación del Dengue en el Perú”

Cesar Munayco Escate (CDC-MoH. Peru)

“Diagnóstico y vigilancia de serotipos y genotipos de Dengue en el Perú, 1990-2023”

Oscar Escalante (Inst. Nacional de Salud-MoH, Peru)

“Comparison of in silico predicted linear B-cell epitopes for Dengue virus with epitopes discovered in a proteome-wide peptide microarray analysis”

Francesca Falconi-Agapito (U Peruana Cayetano Heredia, Peru)

“Knowledge, attitudes, and practices regarding Dengue and Malaria in remote communities of the Peruvian Amazon”

Rosa Angelina Rodriguez-Vasquez (PRISMA, Peru)

“Targeted Indoor Residual Spray (TIRS) for Aedes aegypti with novel chemical compounds”

Helvio Astete (NAMRU-6, Peru)

Wednesday Nov 15
6:15 pm – 7:45 pm

Poster Session B

   At the NOS 5th floor

Exhibition of posters for the following categories:

• Epidemiology – Genomics – Phylogenetics – Modelling – Burden of Disease
• Virology – Pathogenesis – Antivirals
• Human Behavior & Community Engagement

Thursday Nov 16
8:30 am – 10:00 am

Immunology

   At the NOS main auditorium

“Molecular mechanisms underlying flavivirus-dendritic cell interactions”

Sujan Shresta (La Jolla Inst. for Immunology, US)

“Multi-Tissue transcriptomic study in severe Dengue disease: In silico analysis of potential drugs for its management”

Beatriz Sierra (IPK, Cuba)

“Dengue virus NS5 modulates pro-inflammatory cytokine production in a serotype–specific manner”

María Gonzalez Lopez Ledesma (CONICET, Argentina)

“Antibody correlates of severe disease in secondary Dengue virus infection after a primary Zika virus infection: A possible role for IgA”

Jaime Cardona-Ospina (U of California Berkeley, US)

“Depletion of CD8+ T cells reveals CD4+ T cell contribution in controlling Zika viremia in Dengue-immune macaques”

Crisanta Serrano-Collazo (U of Puerto Rico, Puerto Rico)

Thursday Nov 16
10:00 pm – 10:30 pm

   Coffee break

   At the NOS 4th floor

Thursday Nov 16
10:30 am – 12:00 pm

Immunology/Vaccines

   At the NOS main auditorium

“Within-Serotype genetic variation of Dengue virus 2 modulates the neutralization activity of human antibodies “

David Martinez (Yale U., US)

“What we have learned about protective immunity from Dengue controlled human infection and live attenuated vaccine studies”

Anna Durbin (Johns Hopkins, US)

“Efficacy and safety of Takeda’s tetravalent Dengue vaccine candidate (TAK-003) after 4.5 years of follow-up”

Felipe Lorenzato (Takeda, Mexico)

“Tumor Necrosis Factor (TNF) contributes to joint inflammation, hypernociception and disease severity in Chikungunya virus infection: Implications for therapeutic interventions”

Vivian Costa (U. Federal de Minas Gerais, Brazil)

“Development of a powassan virus like particle vaccine adjuvanted with novel toll-like receptor agonists”

Michael Crawford (OHSU, US)

Thursday Nov 16
12:00 pm – 1:30 pm

   Lunch

   At the NOS 4th floor

Thursday Nov 16
1:30 pm – 3:00 pm

Diagnostics / Severity Markers / Prognostics

   At the NOS main auditorium

“Multiplex sample-sparing antibody assay platform for arbovirus surveillance and diagnostics”

Prem Lakshmanane (U of North Carolina-Chapel Hill, US)

“Evaluation of commercial anti-Dengue virus IgG test performance to facilitate dengue immunization”

Freddy Medina (CDC, Puerto Rico)

“Development of chimeric Zika virus proteins for serological diagnosis of low cross-reactivity”

Samille Pereira (U Federal de Minas Gerais, Brazil)

“Perturbed serum metabolome in Dengue virus infection and disease”

Paul Soma (Colorado State U, US)

“Lateral flow tests from qualitative to quantitative approach”

Irene Bosch (Massachusetts Inst. of Technology, US)

Thursday Nov 16
3:00 pm – 3:30 pm

   Coffee break

   At the NOS 4th floor

Thursday Nov 16
3:30 pm – 5:00 pm

Human Behavior & Community Engagement

   At the NOS main auditorium

“Participatory research in Nicaragua: data and community mobilization in the control of aedes aegypti”

Harold Suazo (Sustainable Sciences Inst., Nicaragua)

“Characterization of human mobility to improve Dengue prevention strategies”

Veerle Vanlerberghe (Inst. of Tropical Med., Belgium)

“Estrategias educativas y comunicativas para el control del Dengue en dos poblaciones con alta carga de la enfermedad: Un enfoque en educación en salud”

Santiago Morales-Mesa (U CES, Colombia)

“Effectiveness of the Municipal Strategy for Comprehensive Dengue Control in Xochitepec, Morelos, Mexico”

Hilda Rangel (INS, Mexico)

“Dengvaxia: parental acceptability in Puerto Rico“

Dania Rodriguez (CDC, Puerto Rico)

Thursday Nov 16
5:00 pm – 5:30 pm

   Coffee break

   At the NOS 4th floor

Thursday Nov 16
5:30 pm – 6:30 pm

Round Table: Vector control intervention

   At the NOS main auditorium

Moderator: Amy Morrison (UC-Davis, US/Peru)

Panelists:

Tom Scott  (UC-Davis, US/Peru)
Gonzalo Vasquez-Prokopec (Emory U.,  US/Argentina)
Mauro Teixeira (U Federal de Minas Gerais, Brazil)
Gabriela Paz-Bailey (CDC, Puerto Rico)
Josefina Coloma (UCB, US)

Thursday Nov 16
6:30 pm – 6:45 pm

Closing remarks

   At the NOS main auditorium